The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Jul. 18, 2014
Applicant:

Baylor College of Medicine, Houston, TX (US);

Inventors:

Juan Fernando Vera Valdes, Bellaire, TX (US);

Malcolm Brenner, Bellaire, TX (US);

Usanarat Anurathapan, Houston, TX (US);

Assignee:

Baylor College of Medicine, Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 38/17 (2006.01); A61K 31/706 (2006.01); A61K 35/17 (2015.01); C12N 5/0783 (2010.01); A61K 45/06 (2006.01); A61K 38/16 (2006.01);
U.S. Cl.
CPC ...
A61K 38/177 (2013.01); A61K 31/706 (2013.01); A61K 35/17 (2013.01); A61K 38/164 (2013.01); A61K 45/06 (2013.01); C12N 5/0638 (2013.01); C12N 2501/06 (2013.01); C12N 2501/065 (2013.01); C12N 2510/00 (2013.01);
Abstract

Embodiments of the invention employ methods and compositions for enhancing potency of immune cells that express one or more therapeutic proteins. In certain cases, the methods modulate expression of a CAR transgene in an immune cell, such as a T cell. Specific embodiments employ the exposure of cells and/or individuals to be treated with the cells with an effective amount of at least one agent that upregulates expression of the therapeutic protein, such as a mitogen, histone deacetylase inhibitor, and or DNA methyltransferase inhibitor.


Find Patent Forward Citations

Loading…